Merkliste 
 1 Ergebnisse 
 
1

Phase 1/2 Study of Pepinemab in Combination with Pembrolizu..:

Fisher, T.L. ; Evans, E.E. ; Mallow, C....
International Journal of Radiation Oncology*Biology*Physics.  112 (2022)  5 - p. e36 , 2022